Skip to main content
. 2022 Oct 21;23(20):12661. doi: 10.3390/ijms232012661

Table 1.

Dysbiosis of intestine microbes in chronic liver diseases.

Disease Dysbiosis of the Microbes Metabolite Changes References
Intestinal Leakage Facultative anaerobes LPS ↑
SCFAs ↓
[29]
[30]
NAFLD Firmicutes ethanol ↑
SCFAs ↓
[50]
Bacteroides ↑ [51]
Proteobacteria ↑
Enterobacteriaceae ↑
Escherichia ↑
[52]
Coprococcus
Ruminococcus gnavus ↓
[53]
AFLD Bacteroidaceae ↓
Prevotellaceae
cytolytic hemolysin ↑
candida hemolysin ↑
[75]
Veilonella
Enterococcus faecalis ↑
[76,77]
Candida albicans ↑ [78]
CHB Bifidobacteria
Enterococcus ↓
hepatitis C virus ↑ [86]
Firmicutes ↓
Lactobacillus ↑
[88]
CHC Bacterioidetes ↑
Enterobacteriaceae ↑
Viridans streptococci
Firmicutes ↓
hepatitis B virus ↑
LPS ↑
[93]
Lactobacillus
Streptococcus
Clostridiales
[94]
AIH Veillonella ↑ LPS ↑ [104,107]
Verrucomicrobia [108]
Synergistetes ↓
Lentisphaerae
Proteobacteria ↑
Bacteroidetes
[109]
Bifidobacterium ↓ [104,110]
HCC E. coli ↑ LPS ↑ [117]
Oribacterium ↑ [119]
Fusobacterium ↑
Bacteroides ↑ [120]
Lachnospiracea
Incertae Sedis

LPS, lipopolysaccharides; SCFA, short-chain fatty acids; NAFLD, non-alcoholic fatty liver disease; AFLD, alcoholic fatty liver disease; CHB, chronic hepatitis B; CHC, chronic hepatitis C; AIH, autoimmune liver disease; HCC, hepatocellular carcinoma. “↑” represents the increased abundance of the corresponding bacteria. “↓” represents the decreased abundance of the corresponding bacteria.